INQToday: VP Duterte on dare for her to undergo hair follicle drug test: Let’s do it | Inquirer

INQToday: VP Duterte on dare for her to undergo hair follicle drug test: Let’s do it

/ 12:22 PM August 16, 2024

Here’s a quick roundup of today’s top stories:

Vice President Sara Duterte is willing to be the first to take a hair follicle drug test in response to some requests for such a procedure.

Article continues after this advertisement

Duterte’s pronouncement stemmed from a challenge made by former Presidential Spokesperson Harry Roque.

FEATURED STORIES

The Department of Health (DOH) on Thursday said the country’s surveillance systems had been placed on alert as the World Health Organization declared mpox (formerly monkeypox) a global public health emergency for the second time in two years, following an outbreak in Africa that could spread outside the continent.

No border control measures are being recommended but the Bureau of Quarantine would conduct “interviews, particularly to passengers departing and arriving from countries in Africa,” according to DOH spokesperson Assistant Secretary Albert Domingo.

Article continues after this advertisement

The country’s statistics agency admitted that the food poverty threshold of P63.87 per person a day is ‘insufficient’, stating that it will review the methodology for calculating poverty and food thresholds next year.

“It’s really insufficient but [the way] we set up the food threshold and the poverty threshold is the minimum basic needs, so it’s the least cost,” National Statistician Claire Dennis Mapa said during a briefing.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

MOST READ
www
www
entertainment
entertainment
sports
TAGS: Arsenio Balisacan, Department of Health, DoH, drug test, Food, mpox, PSA, Sara Duterte

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.